TI
NUVB icon

Trexquant Investment’s Nuvation Bio NUVB Stock Holding History

Trexquant Investment’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
485,058
+463,499
+2,150% +$2.27M 0.02% 1050
2026
Q1 		$92.5K Sell
21,559
-165,328
-88% -$921K ﹤0.01% 1707
2025
Q4 		$1.67M Buy
+186,887
New +$1.16M 0.01% 1048
2022
Q2 		– Sell
-44,032
Closed -$232K – 1750
2022
Q1 		$232K Buy
44,032
+19,556
+80% +$110K 0.01% 1134
2021
Q4 		$208K Buy
+24,476
New +$225K 0.01% 1128
2021
Q3 		– Sell
-22,873
Closed -$213K – 1374
2021
Q2 		$213K Buy
+22,873
New +$261K 0.02% 884

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Trexquant Investment's NUVB Position: Q2 2026 in Review

Trexquant Investment increased its Nuvation Bio (NUVB) stake by 2,150% in Q2 2026, buying an estimated $2.27M and bringing the position to 485,058 shares worth $2.76M. The position accounts for 0.02% of the portfolio, ranked #1050.

Trexquant Investment first reported a position in NUVB in Q2 2021 and has held it in 6 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Trexquant Investment held 485,058 shares of Nuvation Bio worth $2.76M as of Q2 2026.
  • Trexquant Investment bought 463,499 Nuvation Bio shares in Q2 2026, an estimated $2.27M.
  • Nuvation Bio made up 0.02% of Trexquant Investment's portfolio in Q2 2026, its #1050 holding.
  • Trexquant Investment first reported a position in Nuvation Bio in Q2 2021 and has held it in 6 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.